Suppr超能文献

抗微生物药物耐药性对癌症管理和结局影响的范围综述方案。

Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes.

机构信息

Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.

Global Cancer Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

出版信息

BMJ Open. 2023 Feb 6;13(2):e068122. doi: 10.1136/bmjopen-2022-068122.

Abstract

INTRODUCTION

Antimicrobial resistance (AMR) is a growing global public health concern and is becoming a significant challenge in the management of patients with cancer. Due to the immunosuppressive nature of cancer treatment, infection is a common complication and the necessary high usage of antibiotics increases the risk of AMR. Failure to adequately prevent and treat infection in patients with cancer as a result of AMR can increase the morbidity and mortality of the disease. The objective of this scoping review is to understand the relationship between AMR and cancer in order to develop effective antimicrobial stewardship in this patient population and minimise the detrimental effects of AMR on cancer outcomes.

METHODS AND ANALYSIS

This scoping review will follow the Arksey and O'Malley methodology framework. An exploratory review of the literature on antibiotic resistance in cancer care will help to define the research questions (stage 1). A broad range of electronic databases (MEDLINE ALL, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Embase) and search terms will be used to retrieve relevant articles published between 2000 and 2021 (stage 2). Studies will be systematically selected based on the eligibility criteria by two independent reviewers (stage 3). The titles and abstracts will be appraised to determine whether articles meet the eligibility criteria. This will be followed by screening of the full texts and only relevant publications will be retrieved. Data will then be extracted, collated and charted (stage 4); and the summary of aggregated results will be presented (stage 5).

ETHICS AND DISSEMINATION

As this scoping review will collect and synthesise data from publicly available sources, no ethics review is required. When data collection and summarisation is completed, results will be disseminated through peer-reviewed publication and the key findings of the review will be presented at relevant conferences.

摘要

简介

抗菌药物耐药性(AMR)是一个日益严重的全球公共卫生问题,并且在癌症患者的管理中成为一个重大挑战。由于癌症治疗具有免疫抑制特性,感染是常见的并发症,而抗生素的大量使用增加了 AMR 的风险。由于 AMR,未能充分预防和治疗癌症患者的感染会增加疾病的发病率和死亡率。本范围综述的目的是了解 AMR 与癌症之间的关系,以便在这一患者群体中制定有效的抗菌药物管理策略,并最大限度地减少 AMR 对癌症结局的不利影响。

方法和分析

本范围综述将遵循阿斯基和奥马利的方法框架。对癌症护理中抗生素耐药性的文献进行探索性综述,有助于确定研究问题(第 1 阶段)。将使用广泛的电子数据库(MEDLINE ALL、Cochrane 对照试验中心注册、Cochrane 系统评价数据库和 Embase)和搜索词检索 2000 年至 2021 年期间发表的相关文章(第 2 阶段)。将根据纳入标准由两名独立评审员系统地选择研究(第 3 阶段)。将评估标题和摘要以确定文章是否符合纳入标准。随后,将筛选全文,仅检索相关出版物。然后将提取、整理和图表化数据(第 4 阶段);并呈现汇总结果的摘要(第 5 阶段)。

伦理和传播

由于本范围综述将从公开来源收集和综合数据,因此不需要进行伦理审查。当数据收集和总结完成后,将通过同行评审出版物进行结果传播,并将在相关会议上介绍综述的主要发现。

相似文献

1
Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes.
BMJ Open. 2023 Feb 6;13(2):e068122. doi: 10.1136/bmjopen-2022-068122.
5
Quality indicators for substance use disorder care: a scoping review protocol.
BMJ Open. 2025 Mar 29;15(3):e085216. doi: 10.1136/bmjopen-2024-085216.
7
Harm reduction for perinatal cannabis use: protocol for a scoping review of clinical practices.
BMJ Open. 2024 Dec 10;14(12):e090453. doi: 10.1136/bmjopen-2024-090453.
8
Scoping review protocol on the use of social media for health research purposes.
BMJ Open. 2021 Feb 11;11(2):e040671. doi: 10.1136/bmjopen-2020-040671.

本文引用的文献

1
The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer.
Cancer Immunol Res. 2020 Oct;8(10):1243-1250. doi: 10.1158/2326-6066.CIR-20-0196. Epub 2020 Jul 27.
2
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy.
Science. 2020 Sep 18;369(6510):1481-1489. doi: 10.1126/science.abc3421. Epub 2020 Aug 13.
4
Antimicrobial Resistance: Implications and Costs.
Infect Drug Resist. 2019 Dec 20;12:3903-3910. doi: 10.2147/IDR.S234610. eCollection 2019.
5
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies.
Cancer Immunol Immunother. 2020 Mar;69(3):343-354. doi: 10.1007/s00262-019-02453-2. Epub 2019 Dec 21.
6
The value of a second reviewer for study selection in systematic reviews.
Res Synth Methods. 2019 Dec;10(4):539-545. doi: 10.1002/jrsm.1369. Epub 2019 Jul 18.
7
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
Ann Intern Med. 2018 Oct 2;169(7):467-473. doi: 10.7326/M18-0850. Epub 2018 Sep 4.
8
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Science. 2018 Jan 5;359(6371):104-108. doi: 10.1126/science.aao3290.
9
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.
10
Infections in Cancer Patients with Solid Tumors: A Review.
Infect Dis Ther. 2017 Mar;6(1):69-83. doi: 10.1007/s40121-017-0146-1. Epub 2017 Feb 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验